| Net Cash Provided by (Used in) Operating Activities |
$62,564 |
USD |
-11359% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$102,500 |
USD |
18673% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
20,000,000,000 |
shares |
-60% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
7,539,209 |
shares |
-100% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$81,317 |
USD |
33364% |
Q4 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$1,707,402 |
USD |
6.5% |
Q2 2025 |
FY 2025 |
| Depreciation |
$39 |
USD |
-58% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,707,402 |
USD |
6.5% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
200 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$16,362,311 |
USD |
11% |
Q4 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
200 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
$503,222 |
USD |
39% |
Q1 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |